Including health economic analysis in pilot studies: lessons learned from a cost-utility analysis within the PROSPECTIV pilot study
Burns RM. et al, (2017), Global and Regional Health Technology Assessment
Should the Republic of Ireland introduce a national prostate-specific antigen testing programme for the secondary detection of prostate cancer? Results from a population-based cost-effectiveness analysis
Burns RM. et al, (2017), In: European Journal of Cancer February 2017Volume 72, Supplement 1, Page S117
Machine perfusion in liver transplantation: practical issues to consider in the design and conduct of a complex multinational interventional trial and the potential impact on the analysis
Chiocchia V. et al, (2017), Trials, 18, 200 - 200
Evidence-gathering across industry and academia on early health technology assessment (HTA) of medical devices: Survey design and piloting
Manetti S. et al, (2017), IFMBE Proceedings, 65, 631 - 634
The burden of healthcare costs associated with prostate cancer in Ireland
Burns RM. et al, (2016), Global and Regional Health Technology Assessment, 4, 0 - 0
Economic burden of malignant blood disorders across Europe: a population-based cost analysis.
Burns R. et al, (2016), Lancet Haematol, 3, e362 - e370
Economic burden of non-malignant blood disorders across Europe: a population-based cost study.
Luengo-Fernandez R. et al, (2016), Lancet Haematol, 3, e371 - e378
Adopting an Evidence Synthesis Approach for Assessing Cost-Effectiveness of Screening Strategies for Prostate Cancer in Ireland.
Burns RM. et al, (2014), Value Health, 17, A552 - A553
The Burden of Health Care Costs Associated with Prostate Cancer in Ireland.
Burns RM. et al, (2014), Value Health, 17
Towards Universal Health Care- A Review of the Basic Basket of Care Associated With Universal Health Care Delivery Models.
Burns RM. et al, (2014), Value Health, 17, A417 - A418
Challenges in generating costs and utilisation rates associated with castration-resistant prostate cancer.
Bourke S. et al, (2014), J Mark Access Health Policy, 2
Factors driving inequality in prostate cancer survival: a population based study.
Burns RM. et al, (2014), PLoS One, 9